Trial intelligence / Profile preview

Butorphanol Pretreatment and Lung Protection Under General Anesthesia

ChiCTR2100047900Phase 4Not yet recruiting

Sponsor
Zunyi Medical University Affiliated Hospital
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of butorphanol in postoperative respiratory complications (PRC) (3 arms), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoints: Respiratory function, Vital signs and 1 more. Planned start Jul 2021; status: not yet recruiting.

02

Drugs

butorphanol
03

Conditions

postoperative respiratory complications (PRC)

Beyond the preview

Go deeper on ChiCTR2100047900.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100047900.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call